Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza

A Arnold S. Monto (Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor) K Klaus Kuhlbusch (F. Hoffmann–La Roche, Basel, Switzerland) C Corrado Bernasconi (Vaderis Therapeutics, Basel, Switzerland) B Bin Cao (The State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China) H Herman Avner Cohen (Pediatric Ambulatory Community Clinic, Petah Tikva, Israel) E Emily Graham (Roche Products, Welwyn Garden City, United Kingdom) A Aeron C. Hurt L Laurie Katugampola (Roche Products, Welwyn Garden City, United Kingdom) T Takashi Kamezawa (Kamezawa Clinic, Kasugai, Japan) A Adam S. Lauring (Department of Microbiology and Immunology, University of Michigan) B Barry McLean (Central Alabama Research, Birmingham) T Takahiro Takazono A Andreas Widmer (University of Basel, Basel, Switzerland) S Steffen Wildum (F. Hoffmann–La Roche, Basel, Switzerland) B Benjamin J. Cowling (School of Public Health, University of Hong Kong, Hong Kong)

Article Details

Volume / Issue Vol. 392, Issue 16
Published April 24, 2025
Pages 1582-1593
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (15)

A

Arnold S. Monto

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor

K

Klaus Kuhlbusch

F. Hoffmann–La Roche, Basel, Switzerland

C

Corrado Bernasconi

Vaderis Therapeutics, Basel, Switzerland

B

Bin Cao

The State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China

H

Herman Avner Cohen

Pediatric Ambulatory Community Clinic, Petah Tikva, Israel

E

Emily Graham

Roche Products, Welwyn Garden City, United Kingdom

A

Aeron C. Hurt

L

Laurie Katugampola

Roche Products, Welwyn Garden City, United Kingdom

T

Takashi Kamezawa

Kamezawa Clinic, Kasugai, Japan

A

Adam S. Lauring

Department of Microbiology and Immunology, University of Michigan

B

Barry McLean

Central Alabama Research, Birmingham

T

Takahiro Takazono

A

Andreas Widmer

University of Basel, Basel, Switzerland

S

Steffen Wildum

F. Hoffmann–La Roche, Basel, Switzerland

B

Benjamin J. Cowling

School of Public Health, University of Hong Kong, Hong Kong